Role of vascular endothelial growth factor in prostate cancer.
about
Involvement of Cyr61 in growth, migration, and metastasis of prostate cancer cellsChemopreventive potential of curcumin in prostate cancerEpidermal growth factor receptor pathway polymorphisms and the prognosis of hepatocellular carcinoma.Epidermal growth factor potentiates in vitro metastatic behaviour of human prostate cancer PC-3M cells: involvement of voltage-gated sodium channel.The endogenous anti-angiogenic VEGF isoform, VEGF165b inhibits human tumour growth in mice.Evaluation of lactate and alanine as metabolic biomarkers of prostate cancer using 1H HR-MAS spectroscopy of biopsy tissues.Evolving perspectives of the role of novel agents in androgen-independent prostate cancer.Androgen receptor and growth factor signaling cross-talk in prostate cancer cells.Adiponectin inhibits VEGF-A in prostate cancer cells.The Androgen Receptor and VEGF: Mechanisms of Androgen-Regulated Angiogenesis in Prostate Cancer.Regulation of VEGF, MMP-9 and metastasis by CXCR4 in a prostate cancer cell line.The role of SRC family kinases in prostate cancer.Different roles of myofibroblasts in the tumorigenesis of nonsmall cell lung cancer.Immunohistochemical Expression of Angiogenic Factors by Neoplastic Epithelial Cells Is Associated With Canine Prostatic Carcinogenesis.Angiogenic and tissue remodeling factors in the prostate of elderly rats submitted to hormonal replacement.The hypothalamic-pituitary-gonadal axis and prostate cancer: implications for androgen deprivation therapy.Applications of high-resolution magic angle spinning MRS in biomedical studies II-Human diseases.
P2860
Q24655999-1D2AE2B1-57A4-48AB-A059-3A1B42FA6F03Q33646014-E9C18933-12BA-4777-BDAD-E3A2AFBFD256Q34991214-3F7B9953-2EBE-4C4D-B8FF-E55F88B3FE19Q36398177-50F630A0-3CAA-4DCF-B835-4F64087BC101Q36608586-276822EB-B75B-47EE-AFD9-8370939D2FF5Q37036880-882061D9-D90E-4349-B843-1D388C65901EQ37197722-B88E5DD0-5242-418D-A18A-D22A604CB5C8Q37230780-C74F3A5F-519A-47D8-B986-DB06D9462991Q38920281-F15869DF-C9EA-4535-879B-8C253A207735Q39231548-DC78F28A-0EAF-410E-B83D-E70C60FFCC96Q39595415-AE033D73-3D4E-4E4F-8798-6FE95D1FA2CCQ40055337-AD77CC2C-789E-4D25-AB1F-18312EF40314Q40414177-23F9F87B-1612-486E-9DE5-72C07A39AC00Q42466619-2AA7A75B-5188-400A-955A-CEF8A1358B12Q44660978-0DA68F4B-BA8E-40D9-BB82-85806CC4E516Q46720614-96815C9D-AAEF-435B-A00E-2AB47E9281BCQ48338205-FDC2986F-032F-4FF2-8DC7-2480727B4EF4
P2860
Role of vascular endothelial growth factor in prostate cancer.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Role of vascular endothelial growth factor in prostate cancer.
@ast
Role of vascular endothelial growth factor in prostate cancer.
@en
type
label
Role of vascular endothelial growth factor in prostate cancer.
@ast
Role of vascular endothelial growth factor in prostate cancer.
@en
prefLabel
Role of vascular endothelial growth factor in prostate cancer.
@ast
Role of vascular endothelial growth factor in prostate cancer.
@en
P1433
P1476
Role of vascular endothelial growth factor in prostate cancer
@en
P2093
Michaël Peyromaure
Nicolas Barry Delongchamps
P304
P356
10.1016/J.UROLOGY.2006.03.010
P407
P577
2006-08-01T00:00:00Z